GOOGLEEarlier this month (August 10), Google announced a restructuring in which its new parent company Alphabet took the helm of the Internet giant and a handful of its offshoot projects, including Google Genomics, an antiaging startup, and a research-and-development (R&D) lab, GoogleX—which partnered with Novartis to help develop smart contacts. In an August 20 post, Google cofounder Sergey Brin announced that the GoogleX Life Sciences team will become a standalone company under Alphabet, led by CEO Andy Conrad.
Under Conrad’s leadership, wrote Brin, Life Sciences will “continue to work with other life-sciences companies to move new technologies from early stage R&D to clinical testing—and, hopefully—transform the way we detect, prevent, and manage disease.”
Hat tip: The Verge
